Literature DB >> 20172123

Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation.

Todd M Dewey1, David L Brown, Morley A Herbert, Dan Culica, Craig R Smith, Martin B Leon, Lars G Svensson, Murat Tuzcu, John G Webb, Alain Cribier, Michael J Mack.   

Abstract

BACKGROUND: Previous coronary artery bypass grafting increases predicted operative risk for conventional valve replacement, according to the Society of Thoracic Surgeons risk algorithm. Additionally, the presence of coronary artery disease (CAD) has been demonstrated to increase procedural risk with conventional aortic valve replacement. Significant coexisting CAD requires preemptive percutaneous coronary intervention (PCI) in patients under consideration for transcatheter aortic valve implantation (TAVI). This study examined the impact of previous coronary artery bypass grafting or PCI on procedural outcomes and overall survival in patients having TAVI.
METHODS: Two hundred and one high-risk patients were enrolled in two international feasibility studies from December 2005 to February 2008 for the treatment of aortic stenosis using TAVI. Thirty patients were excluded from analysis due to failure to successfully deploy the valve in the aortic annulus. Data were collected concurrently using an ad hoc database that included operative and long-term survival. Previous cardiovascular intervention prior to TAVI was used to identify the existence of concomitant CAD. Logistic regression along with Kaplan-Meier estimates were employed to establish the association between CAD and survival from TAVI.
RESULTS: Overall mortality after TAVI was significantly higher among the CAD group (35.7%) in contrast with the non-CAD patients (18.4%), p = 0.01. Logistic regression analysis found that patients who had CAD were 10.1 times more likely to die (95% confidence interval 2.1 to 174.8) within 30 days of the procedure than those who did not. Proportional hazards analysis established that the risk of dying at any point in time was 2.3 times higher among the patients with CAD (95% confidence interval 1.29 to 4.17). Kaplan-Meier survival curves demonstrate improved long-term survival among patients without CAD.
CONCLUSIONS: Coexisting coronary artery disease negatively impacts procedural outcomes and long-term survival in patients undergoing TAVI, and implies that risk assessment and anticipated outcomes might be inaccurate due to stratification as isolated aortic valve replacement rather than AVR+CABG. Comparison of procedural outcomes, based on operative approach without controlling for unequal distribution of CAD in the cohorts, are likely invalid. 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20172123     DOI: 10.1016/j.athoracsur.2009.12.033

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  42 in total

1.  A case of rotational atherectomy after implantation of the Medtronic CoreValve bioprosthesis.

Authors:  Mohamed Abdel-Wahab; Ahmad E Mostafa; Gert Richardt
Journal:  Clin Res Cardiol       Date:  2012-03-13       Impact factor: 5.460

2.  Transcatheter aortic valve implantation in patients with and without concomitant coronary artery disease: comparison of characteristics and early outcome in the German multicenter TAVI registry.

Authors:  Mohamed Abdel-Wahab; Ralf Zahn; Martin Horack; Ulrich Gerckens; Gerhard Schuler; Horst Sievert; Christoph Naber; Matthias Voehringer; Ulrich Schäfer; Jochen Senges; Gert Richardt
Journal:  Clin Res Cardiol       Date:  2012-07-07       Impact factor: 5.460

3.  Challenges of coronary angiography and intervention in patients previously treated by TAVI.

Authors:  Johannes Blumenstein; Won-Keun Kim; Christoph Liebetrau; Luise Gaede; Joerg Kempfert; Thomas Walther; Christian Hamm; Helge Möllmann
Journal:  Clin Res Cardiol       Date:  2015-02-27       Impact factor: 5.460

Review 4.  To revascularize or not before transcatheter aortic valve implantation?

Authors:  Sergio Perez; Torin P Thielhelm; Mauricio G Cohen
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

5.  Does the presence of coronary artery disease affect the outcome of aortic valve replacement?

Authors:  Kaoru Matsuura; Hideki Ueda; Hiroki Kohno; Yusaku Tamura; Michiko Watanabe; Tomohiko Inui; Yuichi Inage; Yasunori Yakita; Goro Matsumiya
Journal:  Heart Vessels       Date:  2017-07-25       Impact factor: 2.037

Review 6.  Coronary Revascularisation in Transcatheter Aortic Valve Implantation Candidates: Why, Who, When?

Authors:  Davide Cao; Mauro Chiarito; Paolo Pagnotta; Bernhard Reimers; Giulio G Stefanini
Journal:  Interv Cardiol       Date:  2018-05

Review 7.  TAVI 2012: state of the art.

Authors:  Jochen Reinöhl; Constantin von Zur Mühlen; Martin Moser; Stefan Sorg; Christoph Bode; Manfred Zehender
Journal:  J Thromb Thrombolysis       Date:  2013-05       Impact factor: 2.300

Review 8.  Timing and Outcomes of PCI in the TAVR Era.

Authors:  Konstantinos V Voudris; Peter Petropulos; Panagiotis Karyofillis; Konstantinos Charitakis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-03-06

9.  Insights on mid-term TAVR performance: 3-year clinical and echocardiographic results from the CoreValve ADVANCE study.

Authors:  Sabine Bleiziffer; Johan Bosmans; Stephen Brecker; Ulrich Gerckens; Peter Wenaweser; Corrado Tamburino; Axel Linke
Journal:  Clin Res Cardiol       Date:  2017-05-08       Impact factor: 5.460

Review 10.  Changing strategy for aortic stenosis with coronary artery disease by transcatheter aortic valve implantation.

Authors:  Junjiro Kobayashi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.